11 May 2021 | Tuesday | News
Image Source : Public Domain
The two-dose mRNA vaccine is already approved for use in those 16 and over. An earlier study showed that the vaccine was 100% effective in adolescents. The move comes amid an effort to drive down the infection rate in the U.S. which has steadily fallen after a plateau in early April.